ENDRA Life Sciences Inc. (NASDAQ:NDRA – Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 104,700 shares, a growth of 2,517.5% from the April 30th total of 4,000 shares. Based on an average daily volume of 184,100 […]
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2023 Earnings Call Transcript March 28, 2024 ENDRA Life Sciences Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.36. NDRA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome […]
14.02.2024 - ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS), announces the issuance of three new patents, including one in the U.S., one in China and one in Europe. ENDRA’s intellectual property portfolio now . Seite 1